Abstract
[Objective] To address the limited oral utilization of metformin hydrochloride (MET) and the insufficient delivery efficiency of conventional liposomes, MET-loaded nanoliposomes modified with Agaricus bisporus chitosan (ACS) (ACS-modified liposomes, A-M-L) were developed, and their physicochemical properties, storage stability, cytocompatibility, and effects on glucose consumption by HepG2 cells were evaluated. [Methods] ACS was used as a substitute for crustacean chitosan to prepare MET-loaded nanoliposomes using the thin-film dispersion-ultrasonication method. The structural characteristics and microscopic morphology were observed by Fourier transform infrared spectroscopy (FTIR) and transmission electron microscopy (TEM), and particle size, polydispersity index (PDI), zeta potential, encapsulation efficiency, storage stability, cytotoxicity, and glucose consumption were determined. [Results] ACS modification improved the physicochemical properties of the liposomes. The 0.5% ACS-modified group exhibited a particle size of approximately 159.45 nm, a low PDI of 0.10, and an initial encapsulation efficiency of 87.46%. Microscopic characterization indicated the successful encapsulation of the drug. After storage at 4 ℃ for 21 days, the particle size increased by only 1.8%, while the encapsulation efficiency remained at 83.1%, indicating good stability under the storage conditions used in this study. In vitro experiments demonstrated that the 1.0% ACS-modified group promoted glucose consumption by HepG2 cells and enhanced glucose metabolism, with glucose consumption reaching 4.9 mmol/L, higher than that in the MET drug group (3.5 mmol/L) and the unmodified liposome group (2.3 mmol/L). In addition, ACS modification effectively attenuated the cytotoxicity of the free drug. [Conclusion] ACS-modified MET-loaded nanoliposomes can improve the dispersibility, encapsulation efficiency, and storage stability of liposomes and increase glucose consumption by HepG2 cells in vitro.
Publication Date
9-20-2026
First Page
140
Last Page
148
DOI
10.13652/j.spjx.1003.5788.2026.80330
Recommended Citation
Yanzhi, Chen; Jiawen, Zhang; Molan, Zhang; and Lijun, You
(2026)
"Preparation of Agaricus bisporus chitosan nanoliposomes and their in vitro hypoglycemic effects,"
Food and Machinery: Vol. 42:
Iss.
8, Article 18.
DOI: 10.13652/j.spjx.1003.5788.2026.80330
Available at:
https://www.ifoodmm.cn/journal/vol42/iss8/18
References
[1] American Diabetes Association Professional Practice Committee for Diabetes.Introduction and methodology:standards of care in diabetes—2026 [J].Diabetes Care,2026,49(Supplement_1):S1-S5.
[2] Foretz M,Guigas B,Bertrand L,et al.Metformin:from mechanisms of action to therapies [J].Cell Metabolism,2014,20(6):953-966.
[3] Graham G G,Punt J,Arora M,et al.Clinical pharmacokinetics of metformin [J].Clinical Pharmacokinetics,2011,50(2):81-98.
[4] Garza-Ocañas L,González-Canudas J,Tamez-De La O E,et al.Comparative bioavailability of metformin hydrochloride oral solution versus metformin hydrochloride tablets in fasting mexican healthy volunteers [J].Advances in Therapy,2019,36(2):407-415.
[5] Majumdar S,Mahanti B,Kar A K,et al.Nanoliposome:as a smart nanocarrier in transdermal drug delivery system [J].Intelligent Pharmacy,2024,2(6):768-776.
[6] 于少轩,逄格雨,张子豪,等.共包埋姜黄素和还原型谷胱甘肽的纳米脂质体的制备、修饰与表征 [J].食品科学,2024,45(6):32-40.Yu S X,Pang G Y,Zhang Z H,et al.Preparation,modification and characterization of nanoliposomes loaded with curcumin and reduced glutathione [J].Food Science,2024,45(6):32-40.
[7] Wang D,Jiang Q,Dong Z F,et al.Nanocarriers transport across the gastrointestinal barriers:the contribution to oral bioavailability via blood circulation and lymphatic pathway [J].Advanced Drug Delivery Reviews,2023,203:115130.
[8] Qiu Y,Zhuo Y,Ye Y Y,et al.Yolk-shell cationic liposomes overcome mucus and epithelial barriers for enhanced oral drug delivery [J].Giant,2024,17:100221.
[9] Sobol Ż,Chiczewski R,Wątróbska-Świetlikowska D.Advances in liposomal drug delivery:multidirectional perspectives on overcoming biological barriers [J].Pharmaceutics,2025,17(7):885.
[10] Azman M,Sabri A H,Anjani Q K,et al.Intestinal absorption study:challenges and absorption enhancement strategies in improving oral drug delivery [J].Pharmaceuticals,2022,15(8):975.
[11] Mohammed Y,Holmes A,Kwok P C L,et al.Advances and future perspectives in epithelial drug delivery [J].Advanced Drug Delivery Reviews,2022,186:114293.
[12] Ni C L,Liao Q H,Ying R F,et al.Recent advances in surface-modified liposomes with polysaccharides for bioactive delivery[J].Food Chemistry,2025,492:145580.
[13] Jiménez-Gómez C P,Cecilia J A.Chitosan:a natural biopolymer with a wide and varied range of applications [J].Molecules,2020,25(17):3 981.
[14] 朱雨晴,刘伟,陈兴,等.叶酸—壳聚糖修饰姜黄素纳米脂质体的制备及其性质 [J].食品科学,2018,39(24):7-13.Zhu Y Q,Liu W,Chen X,et al.Preparation and properties of curcumin nanoliposomes modified by folic acid-chitosan complex [J].Food Science,2018,39(24):7-13.
[15] Edo G I,Yousif E,Al-Mashhadani M H.Chitosan:an overview of biological activities,derivatives,properties,and current advancements in biomedical applications [J].Carbohydrate Research,2024,542:109199.
[16] Pateiro M,Gómez B,Munekata P E S,et al.Nanoencapsulation of promising bioactive compounds to improve their absorption,stability,functionality and the appearance of the final food products [J].Molecules,2021,26(6):1 547.
[17] Tang Y,Liu W,Zhang J,et al.Advances in intestinal-targeted release of phenolic compounds [J].Nutrients,2025,17(16):2 598.
[18] Yan D Z,Li Y Z,Liu Y L,et al.Antimicrobial properties of chitosan and chitosan derivatives in the treatment of enteric infections [J].Molecules,2021,26(23):7 136.
[19] Wani T U,Pandith A H,Sheikh F A.Polyelectrolytic nature of chitosan:influence on physicochemical properties and synthesis of nanoparticles [J].Journal of Drug Delivery Science and Technology,2021,65:102730.
[20] Ways T M,Lau W,Khutoryanskiy V.Chitosan and its derivatives for application in mucoadhesive drug delivery systems [J].Polymers,2018,10(3):267.
[21] Pellis A,Guebitz G M,Nyanhongo G S.Chitosan:sources,processing and modification techniques [J].Gels,2022,8(7):393.
[22] Hussain M,Sam S T,Yaacob N D,et al.Fungal chitosan in focus:a comprehensive review on extraction methods and applications [J].Food Research International,2025,220:117103.
[23] Terkula Iber B,Azman Kasan N,Torsabo D,et al.A review of various sources of chitin and chitosan in nature [J].Journal of Renewable Materials,2022,10(4):1 097-1 123.
[24] Alemu D,Getachew E,Mondal A K.Study on the physicochemical properties of chitosan and their applications in the biomedical sector [J].International Journal of Polymer Science,2023,2 023:5025341.
[25] Riaz Rajoka M S,Zhao L Q,Mehwish H M,et al.Chitosan and its derivatives:synthesis,biotechnological applications,and future challenges [J].Applied Microbiology and Biotechnology,2019,103(4):1 557-1 571.
[26] Guo Y X,Xu M M,Zhang J,et al.Refined regulation of polysaccharide biosynthesis in edible and medicinal fungi:from pathways to production [J].Carbohydrate Polymers,2025,358:123560.
[27] Phimolsiripol Y,Seesuriyachan P.Polysaccharides as active ingredients,nutraceuticals and functional foods [J].International Journal of Food Science & Technology,2022,57(1):1-3.
[28] Wang Y X,Zhao Y J,Li J C,et al.Characterization of a novel acid-stable chitosanase from Lentinula edodes suitable for chitooligosaccharide preparation [J].Foods,2024,13(19):3 127.
[29] Liu C Y,Wang G H,Sui W J,et al.Preparation and characterization of chitosan by a novel deacetylation approach using glycerol as green reaction solvent [J].ACS Sustainable Chemistry & Engineering,2017,5(6):4 690-4 698.
[30] 朱静毅,王威,房克慧,等.不同壳聚糖黏均分子量测定 [J].中国药业,2020,29(23):33-35.Zhu J Y,Wang W,Fang K H,et al.Determination of viscosity-average molecular weight of different chitosan samples [J].China Pharmaceuticals,2020,29(23):33-35.
[31] 陈麟,布海丽且姆·阿卜杜热合曼,姜露熙,等.小白杏多糖的提取、结构表征及抗氧化活性分析 [J].食品与机械,2026,42(2):152-159.Chen L,Abudureheman B,Jiang L X,et al.Extraction and analysis of structural characterization and antioxidant activity analysis of polysaccharides from Xiaobai apricots [J].Food & Machinery,2026,42(2):152-159.
[32] 时振振,白新鹏,岳宜静.椰子油基胆盐脂质体的制备及工艺优化 [J].食品与机械,2021,37(8):207-211.Shi Z Z,Bai X P,Yue Y J.Preparation and process optimization of coconut oil-based bile salt liposomes [J].Food & Machinery,2021,37(8):207-211.
[33] 孙思源,孔令杰,朱和权,等.蜂胶脂质体制备工艺优化及抗氧化活性分析 [J].食品与机械,2024,40(6):192-198,232.Sun S Y,Kong L J,Zhu H Q,et al.Optimization of the preparation process for propolis liposome and antioxidant activity analysis [J].Food & Machinery,2024,40(6):192-198,232.
[34] Lari A S,Zahedi P,Ghourchian H,et al.Microfluidic-based synthesized carboxymethyl chitosan nanoparticles containing metformin for diabetes therapy:in vitro and in vivo assessments[J].Carbohydrate Polymers,2021,261:117889.
[35] Alaaeldin R,Abdel-Rahman I A M,Ali Hassan H,et al.Carpachromene ameliorates insulin resistance in HepG2 cells via modulating IR/IRS1/PI3K/Akt/GSK3/FoxO1 pathway [J].Molecules,2021,26(24):7 629.
[36] Younes I,Rinaudo M.Chitin and chitosan preparation from marine sources:structure,properties and applications [J].Marine Drugs,2015,13(3):1 133-1 174.
[37] Danaei M,Dehghankhold M,Ataei S,et al.Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems [J].Pharmaceutics,2018,10(2):57.
[38] Thamizhchelvan A M,Wells K,Pham J,et al.Nanomaterial-enabled modulation of tumor-associated macrophages and dendritic cells to enhance cancer immunotherapy [J].Nanomaterials,2026,16(3):172.
[39] Frank L A,Onzi G R,Morawski A S,et al.Chitosan as a coating material for nanoparticles intended for biomedical applications [J].Reactive and Functional Polymers,2020,147:104459.
[40] Sebaaly C,Trifan A,Sieniawska E,et al.Chitosan-coating effect on the characteristics of liposomes:a focus on bioactive compounds and essential oils:a review [J].Processes,2021,9(3):445.
[41] Zhao F,Nayyar D,Hwang Y S,et al.Effect of positive charges on liposome stability,uptake efficacy and impact on cells [J].International Journal of Pharmaceutics,2025,681:125881.
[42] Fernandes Queiroz M,Melo K,Sabry D,et al.Does the use of chitosan contribute to oxalate kidney stone formation?[J].Marine Drugs,2015,13(1):141-158.
[43] Bissantz C,Kuhn B,Stahl M.A medicinal chemist's guide to molecular interactions [J].Journal of Medicinal Chemistry,2010,53(14):5 061-5 084.
[44] Wang W J,Xue C H,Mao X Z.Chitosan:structural modification,biological activity and application [J].International Journal of Biological Macromolecules,2020,164:4 532-4 546.
[45] Phan H T,Haes A J.What does nanoparticle stability mean?[J].The Journal of Physical Chemistry C,2019,123(27):16 495-16 507.
[46] Gholami R,Ahmadi E,Ahmadi S.Investigating the effect of chitosan,nanopackaging,and modified atmosphere packaging on physical,chemical,and mechanical properties of button mushroom during storage [J].Food Science & Nutrition,2020,8(1):224-236.
[47] 黎俏灵,李鹤年,郭静科,等.灌胃纳米超氧化物歧化酶脂质体对小鼠溃疡性结肠炎的改善作用 [J].食品科学,2023,44(1):166-174.Li Q L,Li H N,Guo J K,et al.Ameliorative effect of orally administered nano-superoxide dismutase liposomes on ulcerative colitis in mice [J].Food Science,2023,44(1):166-174.
[48] Balan V,Dodi G,Mihai C T,et al.Biotinylated chitosan macromolecule based nanosystems:a review from chemical design to biological targets [J].International Journal of Biological Macromolecules,2021,188:82-93.
